Cohance Lifesciences Limited (BOM:543064)
308.75
+0.60 (0.19%)
At close: Feb 27, 2026
-74.46% (1Y)
| Market Cap | 118.58B |
| Revenue (ttm) | 10.79B |
| Net Income (ttm) | 606.40M |
| Shares Out | n/a |
| EPS (ttm) | 2.35 |
| PE Ratio | 195.54 |
| Forward PE | 33.04 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,599 |
| Average Volume | 176,079 |
| Open | 307.75 |
| Previous Close | 308.15 |
| Day's Range | 303.10 - 314.10 |
| 52-Week Range | 303.10 - 1,246.85 |
| Beta | n/a |
| RSI | 28.99 |
| Earnings Date | Feb 12, 2026 |